H. Robert Horvitz
Howard Hughes Medical Institute
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by H. Robert Horvitz.
Current Biology | 2010
Ezequiel Alvarez-Saavedra; H. Robert Horvitz
MicroRNAs (miRNAs) are approximately 23 nt regulatory RNAs that posttranscriptionally inhibit the functions of protein-coding mRNAs. We previously found that most C. elegans miRNAs are individually not essential for development or viability and proposed that paralogous miRNAs might often function redundantly. To test this hypothesis, we generated mutant C. elegans strains that each lack multiple or all members of one of 15 miRNA families. Mutants for 12 of these families did not display strong synthetic abnormalities, suggesting that these miRNA families have subtle roles during development. By contrast, mutants deleted for all members of the mir-35 or mir-51 families died as embryos or early larvae, and mutants deleted for four members of the mir-58 family showed defects in locomotion, body size, and egg laying and an inability to form dauer larvae. Our findings indicate that the regulatory functions of most individual miRNAs and most individual families of miRNAs related in sequence are not critical for development or viability. Conversely, because in some cases miRNA family members act redundantly, our findings emphasize the importance of determining miRNA function in the absence of miRNAs related in sequence.
Nature | 2003
Ho Yon Hwang; Sara K. Olson; Jeffrey D. Esko; H. Robert Horvitz
Defects in glycosaminoglycan biosynthesis disrupt animal development and can cause human disease. So far much of the focus on glycosaminoglycans has been on heparan sulphate. Mutations in eight squashed vulva (sqv) genes in Caenorhabditis elegans cause defects in cytokinesis during embryogenesis and in vulval morphogenesis during postembryonic development. Seven of the eight sqv genes have been shown to control the biosynthesis of the glycosaminoglycans chondroitin and heparan sulphate. Here we present the molecular identification and characterization of the eighth gene, sqv-5. This gene encodes a bifunctional glycosyltransferase that is probably localized to the Golgi apparatus and is responsible for the biosynthesis of chondroitin but not heparan sulphate. Our findings show that chondroitin is crucial for both cytokinesis and morphogenesis during C. elegans development.
Proceedings of the National Academy of Sciences of the United States of America | 2002
Ho Yon Hwang; H. Robert Horvitz
Recent findings indicate that glycosaminoglycans can play important roles in animal development. The genes sqv-3, -7, and -8, which are necessary for vulval morphogenesis in Caenorhabditis elegans, affect the biosynthesis of chondroitin and heparan sulfate glycosaminoglycans. We cloned sqv-1 and showed that the SQV-1 protein is a type II transmembrane protein that functions as a UDP-glucuronic acid decarboxylase. SQV-1 localizes to punctate cytoplasmic compartments and colocalizes with the SQV-7 nucleotide-sugar transporter, which probably acts in the Golgi apparatus. SQV-1 and SQV-7 are both expressed in the vulva and in oocytes, where they likely act in vulval morphogenesis and embryonic development, respectively. Progeny of sqv-7 and sqv-1 null mutants fail to initiate cytokinesis, possibly because they are unable to separate the plasma membrane from the eggshell, a defect analogous to that of incomplete vulval invagination.
Development | 2006
Erik C. Andersen; Xiaowei Lu; H. Robert Horvitz
The class A, B and C synthetic multivulva (synMuv) genes act redundantly to negatively regulate the expression of vulval cell fates in Caenorhabditis elegans. The class B and C synMuv proteins include homologs of proteins that modulate chromatin and influence transcription in other organisms similar to members of the Myb-MuvB/dREAM, NuRD and Tip60/NuA4 complexes. To determine how these chromatin-remodeling activities negatively regulate the vulval cell-fate decision, we isolated a suppressor of the synMuv phenotype and found that the suppressor gene encodes the C. elegans homolog of Drosophila melanogaster ISWI. The C. elegans ISW-1 protein likely acts as part of a Nucleosome Remodeling Factor (NURF) complex with NURF-1, a nematode ortholog of NURF301, to promote the synMuv phenotype. isw-1 and nurf-1 mutations suppress both the synMuv phenotype and the multivulva phenotype caused by overactivation of the Ras pathway. Our data suggest that a NURF-like complex promotes the expression of vulval cell fates by antagonizing the transcriptional and chromatin-remodeling activities of complexes similar to Myb-MuvB/dREAM, NuRD and Tip60/NuA4. Because the phenotypes caused by a null mutation in the tumor-suppressor and class B synMuv gene lin-35 Rb and a gain-of-function mutation in let-60 Ras are suppressed by reduction of isw-1 function, NURF complex proteins might be effective targets for cancer therapy.
Nature | 1995
Erik M. Jorgensen; Erika Hartwieg; Kim Schuske; Michael L. Nonet; Yishi Jin; H. Robert Horvitz
The Journal of Neuroscience | 1997
Michael L. Nonet; Jane Staunton; Michael P. Kilgard; Tim Fergestad; Erika Hartwieg; H. Robert Horvitz; Erik M. Jorgensen; Barbara J Meyer
Genes & Development | 2000
Yi-Chun Wu; Gillian M. Stanfield; H. Robert Horvitz
Human Molecular Genetics | 1994
Daniel R. Rosen; Allen C. Bowling; David Patterson; Ted B. Usdin; Peter Sapp; Eva Mezey; Diane McKenna-Yasek; Jerimiah O'Regan; Zohra Rahmani; Robert J. Ferrante; Michael J. Brownstein; Neil W. Kowall; M. Flint Beal; H. Robert Horvitz; Robert H. Brown
Human Molecular Genetics | 1994
Jesus Esteban; Daniel R. Rosen; Allen C. Bowling; Peter Sapp; Diane McKenna-Yasek; Jeremiah P. O'Regan; M. Flint Beal; H. Robert Horvitz; Robert H. Brown
Archive | 2014
Randi L. Rawson; Lung Yam; Robby M. Weimer; Eric G. Bend; Erika Hartwieg; H. Robert Horvitz; Scott G. Clark; Erik M. Jorgensen